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AbsTrACT
The treatment of anisometropic or ametropic amblyopia 
has traditionally enjoyed a high treatment success rate. 
Early initiation and consistent use of spectacle correction 
can completely resolve amblyopia in a majority of 
patients. For those with anisometropic amblyopia that 
fail to improve with glasses wear alone, patching or 
atropine penalisation can lead to equalisation of visual 
acuity. However, successful treatment requires full-time 
compliance with refractive correction and this can be a 
challenge for a patient population that often has one 
eye with good acuity without correction. Other barriers 
for a select population with high anisometropic  or 
ametropic amblyopia include rejection of glasses for 
various reasons including discomfort, behavioural or 
sensory problems, postural issues and visually significant 
aniseikonia. When consistent wear of optical correction 
proves difficult and patching/atropine remains a major 
obstacle, surgical correction of refractive error has proven 
success in achieving vision improvement. Acting as a 
means to achieve spectacle independence or reducing 
the overall needed refractive correction, refractive surgery 
can offer a unique treatment option for this patient 
population. Laser surgery, phakic intraocular lenses and 
clear lens exchange are three approaches to altering the 
refractive state of the eye. Each has documented success 
in improving vision, particularly in populations where 
glasses wear has not been possible. Surgical correction 
of refractive error has a risk profile greater than that of 
more traditional therapies. However, its use in a specific 
population offers the opportunity for improving visual 
acuity in children who otherwise have poor outcomes 
with glasses and patching/atropine alone.
InTroduCTIon
A significant difference in refractive error 
(anisometropia) or a large degree of refractive error 
in both eyes (isoametropia) predisposes a child to 
the development of amblyopia. Anisometropia 
may occur in the setting of asymmetric myopia, 
hyperopia or astigmatic error. The amount of 
anisometropia that may generate amblyopia is not 
concrete, but the results of the Multi-Ethnic Pedi-
atric Eye Disease Study established that 59.5% of 
subjects with ≥2 dioptre (D) spherical equivalent 
(SE) of anisometropia had amblyopia.1 The risk 
for amblyopia development is seen with relatively 
smaller differences in hyperopia (≥1.50 D SE) 
or astigmatism (≥2 D SE). In contrast, <3 D SE 
of anisometropia myopia does not usually cause 
amblyopia.2 3 Ametropia guidelines are less exact 
but concern is that those refractions of ≥4 D of 
hyperopia, ≥2.50 D of astigmatism or ≥6 D of 
myopia place a child at risk for amblyopia.2 4
Standard of care practice for refractive amblyopia 
includes correction of the refractive error using 
glasses followed by patching or atropine penalisa-
tion of the fellow eye for anisometropic amblyopia. 
Studies by the Pediatric Eye Disease Investigator 
Group (PEDIG) have carefully defined the amount, 
duration and options for the modification of both 
patching and atropine therapy.5–8 Further improve-
ment in visual acuity occurs with addition of a plano 
lens in the fellow, non-amblyopic eye.9 10
Successful treatment, however, is predicated 
on full-time compliance with refractive correc-
tion. Anisometropic children often have one eye 
with good acuity without correction; therefore, 
they perceive little benefit from glasses and may 
reject them. Other barriers to spectacle compli-
ance include intolerance for a myriad of reasons 
including discomfort with wear, sensory disorders 
and postural issues. Furthermore, higher degrees 
of anisometropia may cause visually significant 
aniseikonia. Two to three dioptres of anisometropia 
induces 5%–6% aniseikonia, a challenging amount 
of image disparity for the brain to resolve.11
High isoametropia, especially those cases of 
severe bilateral myopia, can cause bilateral ambly-
opia or reduced best-corrected visual acuity (BCVA). 
Amblyopia can occur whenever high refractive 
error exists, even in the context of compliance with 
spectacle correction. Object minification due to 
high myopic lenses limits acuity and contributes to 
limited BCVA.12
Contact lens correction (CTL) for the amblyopic 
eye in children with significant anisometropia is an 
acceptable alternative to spectacle correction. CTL 
do not induce aniseikonia for the same degree of 
correction and have the benefit of only nominal 
image minimisation for children with high myopic 
refractive errors. However, the barriers to CTL 
correction are similar to those for spectacle wear 
(no perceived benefit, discomfort, intolerance). 
Additional limitations include parents discomfort 
with CTL handling and placement and the lack of 
coverage on most insurance plans, which further 
dampens parent’s enthusiasm for this approach.
When optical correction cannot be consistently 
worn, patching/atropine remains a major obstacle, 
or for the small subset of patients who have excel-
lent compliance with glasses and amblyopia treat-
ments, yet continue to stall in visual improvement, 
evidence suggests surgical refractive correction is a 
reasonable option to combat amblyopia. The bene-
fits of surgical correction of refractive error are 
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correction for any reason as a barrier to amblyopia treatment and 
has the same benefits as CTL without the associated perceived 
and real drawbacks of CTL use in the paediatric population. 
Furthermore, the ability to reduce anisometropia and resulting 
aniseikonia, even with residual spectacle dependence, is a posi-
tive—and unique—benefit to surgical correction in the treat-
ment of amblyopia.
Laser surgery
Photorefractive keratectomy (PRK), laser in situ keratomileusis 
(LASIK) and laser-assisted subepithelial keratectomy (LASEK) 
have been used to effectively treat refractive errors in the chil-
dren. The first reported use of laser-assisted refractive surgery 
in children was published by Singh in 1995.13 Since that time, 
numerous case reports and series have documented both the 
safety and efficacy of the operation in these patient cohorts. 
The utility of the procedures has been documented to treat high 
hyperopia, high myopia and large amounts of astigmatism. To 
date, no randomised controlled trial has documented the effec-
tiveness of laser-assisted refractive surgery in the treatment of 
amblyopia.
Use of laser-assisted refractive surgery for the treatment of 
myopic anisometropia has been reported in over 17 case series. 
Yin et al described successful use of LASEK in myopic astig-
matism (SE ranged from −15.8 D to −5.4 D) in 32 children. 
BCVA improved from 20/50 to 20/33 and the rates of stereopsis 
improved from 19% to 73%. Incidence of corneal haze was 
low (6/32) and mild.14 In a similarly sized study of 35 patients, 
Tychsen et al treated an even greater range of anisomyopia (SE 
−3.3 D to −24.3 D) using PRK and LASIK.15 Mean BCVA 
improved from 20/87 to 20/47. Low rates of haze were reported. 
Paysse et al reported a similar patient cohort with over 3 years of 
follow-up. This population also included myopes ranging from 
−21.0 D to −9.75 D. In this report, the maximum treatment 
dose was −11.5, which allowed for successful treatment of high 
myopes taking into consideration the need to leave a sufficient 
residual stromal bed.16 Overall, the published studies document 
a trend towards improvement in BCVA. Low rates of complica-
tions were reported in all studies and included minimal haze and 
two incidents of flap dislocation in LASIK patients.
Treatment of anisohyperopia with corneal refractive surgery 
is less extensively reported. It differs from myopic treatments 
in the size and shape of the ablation zone, rendering it slightly 
more challenging and prone to regression.17 18 PRK, LASEK 
and LASIK have shown promise in improving BCVA, binocular 
vision and density of amblyopia. Dvali et al studied an older 
population, mean age of 12.7 years, and had encouraging results. 
Twenty-four patients had improvement in amblyopia and twenty 
had it completely resolve.19 Reassuringly, even treatment of high 
hyperopes did not lead to high rates of corneal haze. Astle and 
colleagues reported on the results of 47 patients undergoing 
LASEK in 72 eyes for the treatment of bilateral hyperopia and 
hyperopic anisometropic amblyopia.18 In this cohort, the upper 
limit of hyperopia treated was +12.5. Among the children able 
to complete acuity testing, a 41.7% improvement in distance 
acuity was seen. There was also improvement in gross and fine 
stereopsis.
High isoametropia, especially severe bilateral myopia, can 
cause bilateral amblyopia or reduced BCVA. Poor spectacle 
compliance is a primary contributing factor to the development 
of bilateral amblyopia. While this is often seen in the setting 
of developmental delay and/or neurobehaviourally impaired 
children who struggle with glasses wear, amblyopia can occur 
whenever high refractive error exists. Minification due to 
high myopic lenses also limits acuity.17 Astle also included an 
example of high bilateral hyperopia in an 11-year old who, 
despite excellent glasses compliance, could not achieve BCVA 
better than 20/80. With LASEK, he improved to 20/40, although 
the postoperative course was complicated by 2+corneal haze.18 
The combined effect of additional magnification and improved 
uncorrected visual acuity can have impressive effects on overall 
function.16 20 
Laser refractive surgery for children is not yet a perfect solu-
tion for the treatment of amblyopia. Despite being well toler-
ated, having low rates of visually significant complications and 
repeatedly documented BCVA gains, there remains room for 
improvement. Regression occurs across all groups of preop-
erative refractive errors.16 Some surgeons advocate the appli-
cation of the antimetabolite mitomycin C during treatment to 
reduce regression in both myopic and hyperopic treatments, but 
controlled studies are lacking.21 Most regression occurs over the 
first year following surgery, with smaller shifts over the following 
2–3 years. Treatment for high myopia generally shows even 
faster rates of regression. Authors suggest anticipating this shift 
and overcorrecting by 1–2 D. Therefore, laser-assisted refractive 
surgery may not free a child from spectacle dependence. More-
over, while the assumption was that with reduced anisometropia 
glasses and patching compliance should improve, but this was 
not reported to be the case.16
Studies have suggested that amblyopia treatment of large 
refractive errors with refractive surgery should take place 
while younger to maximise visual rehabilitation. Astle reported 
successfully treated dense amblyopia from anisomyopia and 
anisoastigmatism in children less than 1 year of age.22 Refractive 
errors were quite large in these cases and amblyopia was felt 
to be unresponsive to all prior forms of treatment. It follows 
that treatment in this age range will require general anaesthesia. 
The logistics of arranging for anaesthesia staff and supplies in 
facilities already containing excimer laser can be complicated. 
However, a practical framework for PRK with general anaes-
thesia has been outlined by Paysse and colleagues.23
Drawbacks linked to treatment-specific complications are as a 
whole quite low. Severe vision compromising complications are 
exceptionally rare. Instances of flap dislocations among LASIK 
patients are reported in the literature, but remain reassuringly 
infrequent.24 Reports of corneal haze are low and generally did 
not become visually significant.16 Most resolved with the use of 
topical steroids. Surgeons continue to look for ways to improve 
their techniques and outcomes, especially in regards to corneal 
clarity and refractive targets. The use of femtosecond tech-
nology, mitomycin C and more precisely selecting good refrac-
tive candidates are all the ways future refractive outcomes may 
continue to improve.
Phakic intraocular lenses (pIoLs) 
pIOLs are available in three models: iris-fixated anterior chamber, 
ciliary sulcus-supported posterior chamber and angle-supported 
anterior chamber. The preference currently appears to be for 
iris-claw anterior chamber IOLs. As noted by Cleary et al, the 
creation of iris-claw lenses took place in the 1970s with the 
original models of what currently are the Artisan and Verysise 
lenses.25 They have undergone modification in the decades since 
and now feature a biconvex design. Hyperopic correction ranges 
from +2 to+30 D and myopic correction ranges from −1.00 to 
−23.50 D. Toric configurations of the Artisan lens can correct 
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reported in children in 1997 in a series of 38 eyes of 27 aphakic 
children.26
High anisomyopic amblyopia has been successfully corrected 
using Artisan and Verysise lenses.20 27–29 Pirouzian and Ip reported 
the successful rehabilitation of seven patients (age 5–11 years) 
with greater than 8 D of myopia with the use of Verysise lenses. 
Each child was entered into the study with a BCVA <20/100. At 
follow-up 3 years later, mean BCVA was 20/40 (range 20/30–
20/60). The mean SE refraction was −14.28 D preoperatively 
and −1.10 D 3 years postoperatively.30 In this group of neurode-
velopmentally normal but non-compliant patients, all improved 
with spectacle wear and occlusion therapy postoperatively.
Tychsen et al reported the successful implantation of Artisan/
Verysise lenses in high myopia and hyperopia in a group of 12 chil-
dren with neurobehavioural disorders.20 This group of patients 
with long-term, severe refractive error has been diagnosed with 
‘visual autism’ (a constellation of symptoms including decreased 
interest in the outside world, fearfulness and markedly with-
drawn social interaction) by the authors.30–33 This report also 
referenced the successful treatment of a high hyperope (mean SE 
+10.3) and outlined the utility of pIOLs in the visual rehabili-
tation of this group of neurodevelopmentally delayed children. 
While not all patients were able to complete comprehensive eye 
examinations, documented improvement by caregivers in visual 
awareness, attentiveness or social interactions was reported. 
Using validated visual function questionnaires, scores improved 
after surgery by 73% in bilateral ametropes and by an average 
58% in anisometropes.20
The Visian implantable collamer lens pIOL is a foldable 
posterior chamber pIOL designed to be placed in the posterior 
chamber behind the iris with the haptic zone resting on the 
ciliary sulcus. This has been approved for use in the correction 
of myopia in adults.34 Correction of anisometropic amblyopia 
in both myopes and hyperopes has been reported with its use. A 
toric form of this lens allowed for successful targeting of astig-
matic anisometropia in children.35
Foremost among concerns about enclavation of pIOLs was 
potential damage to endothelial cells. Improvements in lens 
design have dramatically increased the safety profile. In adults, 
endothelial cell loss has been strictly monitored and remains 
a concern, but has not proved significant enough to deter use 
of the lens. Long-term follow-up of endothelial cell densities 
includes reports with up to 12 years of follow-up data.36 Guide-
lines also specify the use of pIOLs only in situations where ante-
rior chamber depth >3.2 mm.17 Alio et al provided 5 years of 
follow-up on nine children implanted with iris-fixated pIOL for 
anisometropic amblyopia, and endothelial cell count was >2000 
cells/mm2 in 80% of patients. For the remaining patients, eye 
rubbing and ocular trauma was implicated in endothelial cell 
loss.37 Dislocation, pigment dispersion or iris trauma, cataract 
formation and shallowing of the anterior chamber are reported 
rare events in adults.38
Clear lens exchange (CLE)
For extreme refractive errors (>−15.0 D) or instances of shallow 
anterior chambers (<3.2 mm), CLE or refractive lens exchange 
is a suitable solution. With increasing evidence supporting the 
use of IOLs in paediatric cataract surgery, many paediatric 
ophthalmologists feel comfortable with the skills required for 
CLE.39 40 Turning to CLE for ametropia or lensectomy alone 
for high myopes is an effective means to improve in refractive 
error.41 42 Tychsen and coauthors were able to improve visual 
acuity (VA) and correct ametropia within range of the target 
refraction. Average gains in VA are less than that seen in other 
forms of refractive surgery. The authors suggest that their cohort 
had poorer initial acuity and ocular comorbidities than other 
studies of refractive surgery, limiting potential gains.
In contrast to the regression seen after laser correction, which 
may average ∼1 D/year, myopic regression after lens extraction 
appears to be less, on the order of ∼0.5 D/year.37 Regression 
tends to be more pronounced in younger groups of patients 
who undergo CLE.
Highly myopic eyes make up the largest cohort of patients 
receiving CLE or lensectomy and are inherently at greater risk 
for retinal detachments. It has been established in adults that 
risk increases threefold following lens extraction.43 Prophylactic 
barrier laser remains controversial.44 In one study in children, 
one patient sustained a detachment following trauma months 
after CLE.37 Other reports include a higher than expected rate of 
posterior capsule opacification. Most include primary posterior 
capsulotomy as a routine part of their procedure, but still warn 
it may need to be repeated.
summary/conclusions
Refractive surgery has demonstrated benefits for the population 
of children with refractive amblyopia who are non-compliant 
with spectacle wear or non-responsive to standard treatment 
in multiple case series. Evidence also suggests that correction 
of ametropia in children with neurobehavioural disorders that 
preclude spectacle correction improves not only vision but 
also global functioning. Clear lens extraction has shown some 
benefit, but not the robust gains that PRK and pIOL treatments 
have demonstrated. While there are no randomised controlled 
trials to support widespread adoption of these techniques, 
PEDIG is currently planning Amblyopia Treatment Study 19, 
which is a controlled randomised clinical trial that will compare 
PRK versus non-surgical treatment of anisometropic amblyopia 
in children who have failed conventional treatment. The results 
from this trial may provide yet more evidence for the use of 
refractive surgery in the management of amblyopia.
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